Keep Informed on Legal and Compliance Developments Affecting Diagnostic Labs
Best practices and expert insight to help lab professionals comply with regulations and identify strategic trends in business and technology
Already a Subscriber? Log in Here
Lab Industry Advisor Subscription
Struggling with Staying Informed? In the fast-paced world of diagnostic medicine, staying updated with the latest legal, compliance, regulatory, and industry insights is crucial. Yet, finding reliable and comprehensive information can be overwhelming and time-consuming.
Lab Industry Advisor to the Rescue! Lab Industry Advisor provides comprehensive, up-to-date insights and analyses tailored to your needs. With expert commentary and actionable advice, you’ll stay ahead of the curve. No more sifting through endless sources—everything you need is right here!
Start your free trial today and see how Lab Industry Advisor can transform your approach. Get instant access to invaluable resources designed to keep you informed and competitive. Explore detailed reports, in-depth articles, and exclusive industry insights that help you make better decisions faster. Choose from three subscription levels tailored to fit your needs: Essential, Premium, and Elite.
Additional Business Intelligence Offerings
Lab Industry Advisor Subscriptions Include
Analysis and insight on key compliance, legal, and business developments affecting laboratories
- Updates on changes to regulations
- Healthcare-related laws
- FDA approvals
- Business deals in the diagnostics space, and more
Latest Articles
LDTs Rule Update: More Support for Legal Challenges Against FDA
Key clinical laboratory organizations file amicus brief, reiterating that the FDA is overstepping its authority, and its new rule would cause “irreparable patient harm”
Largest Takedown in Strike Force History Alleges $900 Million in False Medicare Billing
From - G2 Compliance Advisor
Nearly a year to the day after another nationwide Strike Force takedown, the Department of Justice announced last week what it says is a…
Genetic Test Registry Finds Growth of Oncology, NGS-Based Tests
From - Diagnostic Testing & Emerging Technologies
The number of cancer gene tests has grown tremendously in the past two years, particularly in the field of oncology where the number of tests grew by…
U.S. Supreme Court Recognizes FCA Liability for Implied False Certification
From - National Intelligence Report
While the long awaited release of the PAMA rule has received a lot of attention, a significant False Claims Act (FCA) decision by the U.S. Supreme Court was also…
Kailos, Huntsman Institute Receive NIH Grant to Develop Cancer Recurrence Test
From - Laboratory Industry Report
The Alabama-based Kailos Genetics and the Huntsman Cancer Institute at the University of Utah have received a $2.4 million grant from the…
Final PAMA Rule Released, Implementation Delayed to 2018
From - National Intelligence Report
After much lobbying, debate and delay, the Centers for Medicare & Medicaid Services (CMS) final rule implementing the Protecting Access to Medicare Act (PAMA) changes to the Clinical Laboratory Fee Schedule (CLFS) was released…
Data Analytics Fuels Billions of Dollars in Fraud Recoveries Says OIG, CMS
From - G2 Compliance Advisor
A common message emerging from the government enforcement agencies is that data analytics have been critical to fraud and…
USPSTF Updates Colorectal Cancer Screening Guidelines to Include Molecular Test
From - Diagnostic Testing & Emerging Technologies
The U.S. Preventive Services Task Force (USPSTF) added molecular colorectal cancer (CRC) screening to its newly updated guidelines, but stopped short of…